Skip to main content
Innovation in Aging logoLink to Innovation in Aging
. 2017 Jun 30;1(Suppl 1):780. doi: 10.1093/geroni/igx004.2827

FIFTEEN-YEAR EXPERIENCE IN APPLICATION OF PINEAL GLAND PEPTIDES IN ELDERLY SUBJECTS

O Korkushko 2, V Shatylo 1, V Khavinson 3
PMCID: PMC6250149

Abstract

In recent years discussions have been held on the significance of pineal gland functioning changes in aging and age related pathologies.

The purpose of study was to evaluate the latest results of long-term use of pineal gland peptides (PGP) in elderly patients with coronary artery disease (CAD).

79 patients with stable angina (2nd functional class), aged 65 ± 3, with low nocturnal pineal melatonin level (PML < 40 ng/l at 3 a.m.) were selected and divided into 2 groups. The 1st group patients (n=39) were administered PGP during 3 years (i.m. 10 mg once in 3 days, 5 injections during each course, intervals between courses being 6 months). The 2nd group patients (n=40) were not prescribed PGP. Patients of each group were receiving low doses of acetylsalicylic acid, ACE inhibitor, beta-blocker and statin. Results were assessed by measuring PML, indices of physical working capacity, changes in blood lipids and glucose. In addition, over 15 years we have verified causes of fatalities.

After 1st and subsequent courses with PGP there occurred a more than 2-fold increase in the nocturnal PML. Against this background, exercise endurance was improved and thereafter physical capacity kept higher levels. Within PGP administration, the elevated LDL cholesterol levels decreased. Plasma glucose levels also decreased at fasting and at standard oral glucose tolerance test. The number of patients with glucose intolerance reduced from 56% to 24%. No positive changes were seen in 2nd group. After 15 years since we began using PGP in our patients, there remained 26 of 39 survivals (66.7%) among them. In the 2nd group only 16 of 40 (40%) CAD patients have survived over the same period. Prolonged use of PGP has reduced cardiovascular mortality.

So, pineal gland peptides has restored pineal gland activity in elderly CAD patients, improved their physical working capacity, lipid and carbohydrate metabolism, and significantly reduced a risk of premature death due to cardiovascular events.


Articles from Innovation in Aging are provided here courtesy of Oxford University Press

RESOURCES